(Q98749062)
Statements
A Non-randomized, Open-label, Non-controlled Phase I/II Study to Assess Safety and Immunogenicity of Two Doses of Intramuscular AG0301-COVID19 (1mg/2mg) in Healthy Adults (English)
0 references
29 June 2020
0 references
31 July 2020
0 references
30
0 references
20 years old
0 references
65 years old
0 references